Target intelligence / Profile preview

HIV-1 Rev-responsive element IIB RNA (RRE IIB)

Target
RRE IIB
Molecular classification
RNA, Viral RNA element, Ribonucleic acid
01

Overview

The HIV-1 Rev-responsive element IIB RNA (RRE IIB) is a highly structured RNA motif located within the env gene of the HIV-1 genome (Kjems et al., 1991, PNAS). It functions as the high-affinity docking site for the viral Rev protein, which is a prerequisite for the nuclear export of unspliced and singly spliced viral mRNA transcripts (Battiste et al., 1996, Science). This export process is vital for the synthesis of viral structural proteins and the packaging of the viral genome, making it a cornerstone of the HIV-1 replication cycle (Pollard and Malim, 1998, Annu Rev Microbiol). Disrupting the Rev-RRE IIB interaction leads to the nuclear retention and degradation of these transcripts, effectively preventing the assembly of new infectious particles. Consequently, RRE IIB is a prominent therapeutic target for small-molecule inhibitors, such as aminoglycosides and synthetic ligands, designed to block Rev binding (Zapp et al., 1993, Cell). Despite its potential, the primary challenge in targeting RRE IIB is ensuring selectivity to avoid interfering with essential host RNA-protein interactions, such as those involving the ribosome (Jayaraman et al., 2014, Bioorg Med Chem).

Other names
RRE Stem-loop IIBRev-binding elementRBEHIV-1 RRE Stem IIBRev-responsive element
02

Mechanism of action

Inhibition of the Rev-RRE interaction, which prevents the nuclear export of unspliced and singly spliced viral mRNA, thereby blocking the production of viral structural proteins.

03

Biological functions

Viral mRNA nuclear exportViral replicationRNA-protein interactionRegulation of viral gene expression
04

Disease associations

HIV-1 infectionAcquired Immunodeficiency Syndrome (AIDS)
05

Safety considerations

Off-target binding to host cellular RNA (e.g., ribosomal RNA)Potential toxicity of aminoglycoside-based inhibitors (nephrotoxicity, ototoxicity)High mutation rate of HIV leading to potential resistance in the RNA structure
06

Interacting drugs

Neomycin B

4 more in the full profile.

07

Biomarkers

HIV-1 viral loadCD4+ T-cell count

Beyond the preview

Go deeper on HIV-1 Rev-responsive element IIB RNA (RRE IIB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 Rev-responsive element IIB RNA (RRE IIB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call